Literature DB >> 7894494

Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.

A Hemminki1, P Peltomäki, J P Mecklin, H Järvinen, R Salovaara, M Nyström-Lahti, A de la Chapelle, L A Aaltonen.   

Abstract

The mechanism by which germline mutations of DNA mismatch repair genes cause susceptibility to tumour formation is not yet understood. Studies in vitro indicate that heterozygosity for these mutations, unlike homozygosity, does not affect mismatch repair. Surprisingly, no loss of heterozygosity at the predisposing loci has so far been described in hereditary nonpolyposis colorectal cancers. Here, we show that loss of heterozygosity (LOH) of markers within or adjacent to the MLH1 gene on chromosome 3p occurs nonrandomly in tumours from members of families in which the disease phenotype cosegregates with MLH1. In every informative case, the loss affects the wild type allele. These results suggest that DNA mismatch repair genes resemble tumour suppressor genes in that two hits are required to cause a phenotypic effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7894494     DOI: 10.1038/ng1294-405

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  66 in total

1.  Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction.

Authors:  K D Berg; C L Glaser; R E Thompson; S R Hamilton; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions.

Authors:  Jérémie H Lefevre; Chrystelle Colas; Florence Coulet; Carolina Bonilla; Najat Mourra; Jean-Francois Flejou; Emmanuel Tiret; Walter Bodmer; Florent Soubrier; Yann Parc
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Short-patch correction of C/C mismatches in human cells.

Authors:  Regula Muheim-Lenz; Tonko Buterin; Giancarlo Marra; Hanspeter Naegeli
Journal:  Nucleic Acids Res       Date:  2004-12-21       Impact factor: 16.971

4.  hMLH1 and hMSH2 somatic inactivation mechanisms in sporadic colorectal cancer patients.

Authors:  Enikô Kámory; Orsolya Kolacsek; Szabolcs Ottó; Orsolya Csuka
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

Review 5.  Immune checkpoint inhibitors in gastrointestinal malignancies.

Authors:  Vishal Jindal
Journal:  J Gastrointest Oncol       Date:  2018-04

6.  Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia.

Authors:  Qian Li; Xiao-Ji Lin; Hui Chen; Jian Gong; Zhen Li; Xiang-Nan Chen
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

7.  Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Authors:  Robert M W Hofstra; Amanda B Spurdle; Diana Eccles; William D Foulkes; Niels de Wind; Nicoline Hoogerbrugge; Frans B L Hogervorst
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

8.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Genomic instability and carcinogenesis: an update.

Authors:  Wael M Abdel-Rahman
Journal:  Curr Genomics       Date:  2008-12       Impact factor: 2.236

10.  Microsatellite instability in the peripheral blood leukocytes of HNPCC patients.

Authors:  Mary I Coolbaugh-Murphy; Jing-Ping Xu; Louis S Ramagli; Brian C Ramagli; Barry W Brown; Patrick M Lynch; Stanley R Hamilton; Marsha L Frazier; Michael J Siciliano
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.